Abalos Therapeutics GmbH, of Essen, Germany, appointed Klaus Binder chair of its board and Dethardt Müller chief technology officer.
Aerami Therapeutics Inc., of Durham, N.C., appointed Timm Crowder chief operating officer.
Amylyx Pharmaceuticals Inc., of Cambridge, Mass., appointed Jeffrey Trigilio chief financial officer.
Arrakis Therapeutics Inc., of Waltham, Mass, appointed Jacques Dumas senior vice president, drug discovery.
Atara Biotherapeutics Inc., of South San Francisco, appointed Kristin Yarema chief commercial officer, effective Feb. 18, 2020.
Epirium Bio Inc., of San Diego, appointed Ransi Somaratne chief medical officer.
Generex Biotechnology Corp., of Miramar, Fla., appointed Carol Nacy to the board of Nugenerex Immuno-Oncology.
Khondrion BV, of Nijmegen, the Netherlands, appointed Rob van Maanen chief medical officer.
Magenta Therapeutics Inc., of Cambridge, Mass., appointed Kristen Stants chief people officer and Li Malmberg senior vice president, head of manufacturing.